400 related articles for article (PubMed ID: 27013255)
1. Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.
Swamy MN; Wu H; Shankar P
Adv Drug Deliv Rev; 2016 Aug; 103():174-186. PubMed ID: 27013255
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic landscape of HIV-1 via genome editing.
Kwarteng A; Ahuno ST; Kwakye-Nuako G
AIDS Res Ther; 2017 Jul; 14(1):32. PubMed ID: 28705213
[TBL] [Abstract][Full Text] [Related]
4. Genome editing strategies: potential tools for eradicating HIV-1/AIDS.
Khalili K; Kaminski R; Gordon J; Cosentino L; Hu W
J Neurovirol; 2015 Jun; 21(3):310-21. PubMed ID: 25716921
[TBL] [Abstract][Full Text] [Related]
5. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
Han Y; Li QW
Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
[TBL] [Abstract][Full Text] [Related]
6. Newer gene editing technologies toward HIV gene therapy.
Manjunath N; Yi G; Dang Y; Shankar P
Viruses; 2013 Nov; 5(11):2748-66. PubMed ID: 24284874
[TBL] [Abstract][Full Text] [Related]
7. CRISPR therapy towards an HIV cure.
Herrera-Carrillo E; Gao Z; Berkhout B
Brief Funct Genomics; 2020 May; 19(3):201-208. PubMed ID: 31711197
[TBL] [Abstract][Full Text] [Related]
8. TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus.
Senís E; Mockenhaupt S; Rupp D; Bauer T; Paramasivam N; Knapp B; Gronych J; Grosse S; Windisch MP; Schmidt F; Theis FJ; Eils R; Lichter P; Schlesner M; Bartenschlager R; Grimm D
Nucleic Acids Res; 2017 Jan; 45(1):e3. PubMed ID: 27614072
[TBL] [Abstract][Full Text] [Related]
9. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
10. Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4
Liu Z; Chen S; Jin X; Wang Q; Yang K; Li C; Xiao Q; Hou P; Liu S; Wu S; Hou W; Xiong Y; Kong C; Zhao X; Wu L; Li C; Sun G; Guo D
Cell Biosci; 2017; 7():47. PubMed ID: 28904745
[TBL] [Abstract][Full Text] [Related]
11. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
[TBL] [Abstract][Full Text] [Related]
12. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.
Xiao Q; Guo D; Chen S
Front Cell Infect Microbiol; 2019; 9():69. PubMed ID: 30968001
[TBL] [Abstract][Full Text] [Related]
13. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic application of CRISPR/Cas9 technologies for HIV.
Saayman S; Ali SA; Morris KV; Weinberg MS
Expert Opin Biol Ther; 2015 Jun; 15(6):819-30. PubMed ID: 25865334
[TBL] [Abstract][Full Text] [Related]
15. A CRISPR-Cas Cure for HIV/AIDS.
Hussein M; Molina MA; Berkhout B; Herrera-Carrillo E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675077
[TBL] [Abstract][Full Text] [Related]
16. Versatile Viral Vector Strategies for Postscreening Target Validation and RNAi ON-Target Control.
Christel CJ; Schmied P; Jagusch V; Schrödel S; Thirion C; Schmitt K; Salomon M
J Biomol Screen; 2015 Sep; 20(8):976-84. PubMed ID: 25873558
[TBL] [Abstract][Full Text] [Related]
17. RNAi as a treatment for HIV-1 infection.
Rossi JJ
Biotechniques; 2006 Apr; Suppl():25-9. PubMed ID: 16629384
[TBL] [Abstract][Full Text] [Related]
18. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
Liu YP; Westerink JT; ter Brake O; Berkhout B
Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
[TBL] [Abstract][Full Text] [Related]
19. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
Berkhout B; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow Gene Therapy for HIV/AIDS.
Herrera-Carrillo E; Berkhout B
Viruses; 2015 Jul; 7(7):3910-36. PubMed ID: 26193303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
